Molecular Partners AG has appointed Lisa Rojkjaer, former head of clinical development at MorphoSys AG, to the position of chief medical officer. Dr Rojkjaer will manage clinical development with a view to broadening the company’s pipeline. Dr Rojkjaer holds a medical degree from the University of Toronto and is a board-certified haematologist. She has also held senior positions at both Novartis and Novo Nordisk.
Molecular Partners announced the appointment on 1 June 2012.
Copyright 2012 Evernow Publishing Ltd